Benevich Eric
- SEC CIK
- 0001643653
In the past year, 2 open-market sale filings worth $1.24M and no purchases.
Current role at each company
- NBIX Neurocrine Biosciences IncChief Commercial Officeras of Sep 15, 2026
- ATYR aTYR PHARMA INCDirectoras of May 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.24M
- 2 filings
- Net
- −$1.24M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Benevich Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NBIX Neurocrine Biosciences Inc
Chief Commercial Officer21 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Benevich EricChief Commercial Officer | SSale | −5.63K | $89.62 | −$504.4K | −26.5%15.6K after | |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Benevich EricChief Commercial Officer | SSale | −5.10K | $80.57 | −$410.8K | −20.0%20.3K after | 4 lots |
| Oct 19, 2022 (view filing) | Oct 17 | 2 days | Benevich EricChief Commercial Officer | SSale | −4.96K | $110.82 | −$549.7K | −24.1%15.6K after | |
| Nov 4, 2022 (view filing) | Nov 2-3 | 2 days | Benevich EricChief Commercial Officer | SSale | −9.37K | $125.02 | −$1.17M | −37.5%15.6K after | 2 lots |
| Nov 10, 2022 (view filing) | Nov 8-10 | 2 days | Benevich EricChief Commercial Officer | SSale | −24.7K | $125.33 | −$3.09M | −61.2%15.6K after | 2 lots |
| Dec 1, 2022 (view filing) | Nov 30 | 1 day | Benevich EricChief Commercial Officer | SSale | −50.0K | $125.90 | −$6.29M | −76.2%15.6K after | 3 lots |
| Jan 10, 2023 (view filing) | Jan 6 | 4 days | Benevich EricChief Commercial Officer | SSale | −400 | $125.00 | −$50.0K | −2.5%15.6K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Benevich EricChief Commercial Officer | SSale | −1.21K | $109.95 | −$132.7K | −6.7%16.7K after | |
| Feb 8, 2023 (view filing) | Feb 6-8 | 2 days | Benevich EricChief Commercial Officer | SSale | −19.6K | $102.70 | −$2.02M | −36.4%34.4K after | 4 lots |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Benevich EricChief Commercial Officer | SSale | −1.60K | $107.40 | −$171.8K | −4.2%36.4K after | 10b5-1 |